Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?

J Clin Oncol. 2006 Jun 10;24(17):2683-4; author reply 2684. doi: 10.1200/JCO.2006.06.4345.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticoagulants / therapeutic use
  • Blood Coagulation / drug effects
  • Female
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Hormone Replacement Therapy / adverse effects*
  • Humans
  • Lipoproteins / metabolism*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / mortality*
  • Randomized Controlled Trials as Topic

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Lipoproteins
  • lipoprotein-associated coagulation inhibitor